N-(5-tert-Butylisoxazol-3-yl)-N’-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea CAS#: 950769-58-1; 凯望编码 (ChemWhat Code): 1365992

N-(5-tert-Butylisoxazol-3-yl)-N’-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea Basic information
英文名 N-(5-tert-Butylisoxazol-3-yl)-N’-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea
别名 N-(5-tert-Butylisoxazol-3-yl)-N’-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea AC-220;quizartinib (FLT3 inhibitor);1-(5-(tert-Butyl)isoxazol-3-yl)-3-(4-(7-(2-morpholinoethoxy)-benzo[d]imidazo[2,1-b]thiazol-2-y;N-(5-tert-Butylisoxazol-3-yl)-N’-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea;Quizartinib;Quizartinib AC-220;2-(4-AMinophenyl)-7-(2-Morpholin-4-yl-ethoxy)iMidazo[2,1-b]-[1,3]benzothiazole;N-(5-tert-Butylisoxazol-3-yl)-N’-{4-[7-(2-Morpholin-4-ylethoxy)iMidazo[2,1-b][1,3]benzothiazol-2-yl]
CAS编号 950769-58-1
分子式 C29H32N6O4S
分子量 560.66718
EINECS
Other Registry Numbers Inhibitors;Anti-cancer;Inhibitor;Antineoplastic
IUPA Names, InChI, InChI Key, Canonical SMILES, etc.: 950769-58-1.mol
N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea Structure
N-(5-tert-Butylisoxazol-3-yl)-N’-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea Chemical Properties

Safety & Hazards(Codes & Phrases)
More Safety & Hazards From PubChem Signal, GHS Hazard Statements, Precautionary Statement Codes, etc.

Literature
Literature on PubChem Synthesis References, Metabolite References, etc.

Patents
Patents on PubChem Related Patents Of This Product

Transportation, Storage & Usage
Transportation No Information
Storage No Information
Usage No Information

Spectral Properties
No Information

试剂采购

没有试剂厂商? 向凯望发送快速询价
想要被列为试剂厂商? (付费服务) 点击这里联系凯望

认证生产商

想要被列为认证生产商 (需要通过认证)? 请下载并填写 这份表格并发邮件到approved-manufacturers@chemwhat.com

其他供应商

Watson International Limited 访问Watson官网

如需其他帮助，请联系我们

联系我们获取其它信息或服务 点击这里联系凯望